MAXIMUS, Inc. (NYSE:MMS) Vice Chairman Richard A. Montoni sold 30,000 shares of the firm’s stock in a transaction on Tuesday, December 4th. The shares were sold at an average price of $72.03, for a total value of $2,160,900.00. Following the transaction, the insider now owns 429,874 shares in the company, valued at approximately $30,963,824.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
MMS stock traded up $0.10 during trading on Friday, reaching $70.48. 18,416 shares of the company traded hands, compared to its average volume of 415,831. MAXIMUS, Inc. has a 12 month low of $60.00 and a 12 month high of $72.71. The company has a market cap of $4.54 billion, a P/E ratio of 20.73, a PEG ratio of 1.93 and a beta of 1.03.
MAXIMUS (NYSE:MMS) last issued its quarterly earnings data on Tuesday, November 20th. The health services provider reported $0.71 earnings per share for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.01). MAXIMUS had a net margin of 9.23% and a return on equity of 20.23%. The company had revenue of $558.50 million for the quarter, compared to the consensus estimate of $587.58 million. During the same period in the previous year, the business earned $0.81 EPS. MAXIMUS’s revenue for the quarter was down 10.0% compared to the same quarter last year. On average, sell-side analysts predict that MAXIMUS, Inc. will post 3.66 EPS for the current fiscal year.
MMS has been the topic of several research reports. Canaccord Genuity raised their price target on MAXIMUS from $64.00 to $67.00 and gave the company a “hold” rating in a research note on Wednesday, October 10th. Zacks Investment Research raised MAXIMUS from a “hold” rating to a “buy” rating and set a $71.00 price objective on the stock in a research report on Friday, November 23rd. Finally, ValuEngine raised MAXIMUS from a “hold” rating to a “buy” rating in a research report on Friday, November 30th. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $72.00.
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Marshall Wace LLP acquired a new stake in MAXIMUS in the third quarter worth about $2,332,000. Clearbridge Investments LLC boosted its holdings in MAXIMUS by 9.7% in the third quarter. Clearbridge Investments LLC now owns 417,514 shares of the health services provider’s stock worth $27,163,000 after acquiring an additional 37,076 shares in the last quarter. Vanguard Group Inc. boosted its holdings in MAXIMUS by 0.8% in the third quarter. Vanguard Group Inc. now owns 6,767,684 shares of the health services provider’s stock worth $440,305,000 after acquiring an additional 52,238 shares in the last quarter. Nordea Investment Management AB boosted its holdings in MAXIMUS by 41.9% in the third quarter. Nordea Investment Management AB now owns 71,423 shares of the health services provider’s stock worth $4,647,000 after acquiring an additional 21,092 shares in the last quarter. Finally, AQR Capital Management LLC boosted its holdings in MAXIMUS by 29.6% in the third quarter. AQR Capital Management LLC now owns 906,088 shares of the health services provider’s stock worth $58,950,000 after acquiring an additional 206,896 shares in the last quarter. 93.29% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: “Richard A. Montoni Sells 30,000 Shares of MAXIMUS, Inc. (MMS) Stock” was reported by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://dakotafinancialnews.com/2018/12/07/richard-a-montoni-sells-30000-shares-of-maximus-inc-mms-stock.html.
MAXIMUS Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.
Recommended Story: What are the reasons investors use put options?
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.